Code of Federal Regulations (alpha)

CFR /  Title 21  /  Part 26: Mutual Recognition Of Pharmaceutical Good Manufacturing Practice Reports, Medical Device Quality System Audit Reports, And Certain Medical Device Product Evaluation Reports: United States And The European Community

Section No. Description
Section 26.0 Definitions
Section 26.1 Purpose
Section 26.2 Scope
Section 26.3 Product coverage
Section 26.4 Length of transition period
Section 26.5 Equivalence assessment
Section 26.6 Participation in the equivalence assessment and determination
Section 26.7 Other transition activities
Section 26.8 Equivalence determination
Section 26.9 Regulatory authorities not listed as currently equivalent
Section 26.10 Start of operational period
Section 26.11 Nature of recognition of inspection reports
Section 26.12 Transmission of postapproval inspection reports
Section 26.13 Transmission of preapproval inspection reports
Section 26.14 Monitoring continued equivalence
Section 26.15 Suspension
Section 26.16 Role and composition of the Joint Sectoral Committee
Section 26.17 Regulatory collaboration
Section 26.18 Information relating to quality aspects
Section 26.19 Alert system
Section 26.20 Safeguard clause
Section 26.21 Purpose
Section 26.31 Scope
Section 26.32 Product coverage
Section 26.33 Regulatory authorities
Section 26.34 Length and purpose of transition period
Section 26.35 Listing of CAB's
Section 26.36 Confidence building activities
Section 26.37 Other transition period activities
Section 26.38 Equivalence assessment
Section 26.39 Start of the operational period
Section 26.40 Exchange and endorsement of quality system evaluation reports
Section 26.41 Exchange and endorsement of product evaluation reports
Section 26.42 Transmission of quality system evaluation reports
Section 26.43 Transmission of product evaluation reports
Section 26.44 Monitoring continued equivalence
Section 26.45 Listing of additional CAB's
Section 26.46 Role and composition of the Joint Sectoral Committee
Section 26.47 Harmonization
Section 26.48 Regulatory cooperation
Section 26.49 Alert system and exchange of postmarket vigilance reports
Section 26.50 Definitions
Section 26.60 Purpose of this part
Section 26.61 General obligations
Section 26.62 General coverage of this part
Section 26.63 Transitional arrangements
Section 26.64 Designating authorities
Section 26.65 Designation and listing procedures
Section 26.66 Suspension of listed conformity assessment bodies
Section 26.67 Withdrawal of listed conformity assessment bodies
Section 26.68 Monitoring of conformity assessment bodies
Section 26.69 Conformity assessment bodies
Section 26.70 Exchange of information
Section 26.71 Sectoral contact points
Section 26.72 Joint Committee
Section 26.73 Preservation of regulatory authority
Section 26.74 Suspension of recognition obligations
Section 26.75 Confidentiality
Section 26.76 Fees
Section 26.77 Agreements with other countries
Section 26.78 Territorial application
Section 26.79 Entry into force, amendment, and termination
Section 26.80 Final provisions
Section 26.81 Scope